Skip to content

13F-HR filed by SAMSARA BIOCAPITAL, LLC

SAMSARA BIOCAPITAL, LLC filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 56 holding rows worth $428,862,000.

Accession
0001104659-22-118511
Filed
2022-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2022

A holdings report, 56 entries on the cover page, a total value of $428,862,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $428,862,000 with VALUE read as thousands by filing date, 13F file number 028-19375. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CHINOOK THERAPEUTICS INC16961L106COM5,161,888$101,483,000thousands by filing date
NKARTA INC65487U108COMMON STOCK2,868,035$37,743,000thousands by filing date
SCHOLAR ROCK HLDG CORP80706P103COM4,598,828$31,870,000thousands by filing date
GRAPHITE BIO INC38870X104COM8,459,314$26,816,000thousands by filing date
FORMA THERAPEUTICS HLDGS INC34633R104SHS1,065,413$21,255,000thousands by filing date
ARCELLX INC COMMON STOCK03940C100Stock1,063,835$19,968,000thousands by filing date
IVERIC BIO INC46583P102COM808,041$14,496,000thousands by filing date
ACLARIS THERAPEUTICS INC COM00461U105Stock696,171$10,958,000thousands by filing date
HILLEVAX INC43157M102COM610,062$10,426,000thousands by filing date
VERONA PHARMA PLC925050106SPONSORED ADS938,890$9,595,000thousands by filing date
SUTRO BIOPHARMA INC869367102COM1,675,579$9,299,000thousands by filing date
INTERCEPT PHARMACEUTICALS IN45845P108COM640,688$8,938,000thousands by filing date
LYRA THERAPEUTICS INC55234L105COM1,777,251$8,904,000thousands by filing date
Instil Bio, Inc.45783C101Common Stock1,788,280$8,655,000thousands by filing date
RHYTHM PHARMACEUTICALS INC76243J105COM345,293$8,460,000thousands by filing date
RAIN ONCOLOGY INC75082Q105COM1,560,652$7,616,000thousands by filing date
CENTESSA PHARMACEUTICALS PLC152309100SPONSORED ADS1,693,736$6,809,000thousands by filing date
ZYMEWORKS INC98985W102COM970,987$5,972,000thousands by filing date
PEPGEN INC COM713317105Stock651,050$5,912,000thousands by filing date
SYROS PHARMACEUTICALS INC87184Q107COM881,450$5,677,000thousands by filing date
DICE THERAPEUTICS INC23345J104COM253,466$5,140,000thousands by filing date
JIYA ACQUISITION CORP47760M102CMN507,041$5,055,000thousands by filing date
JANUX THERAPEUTICS INC47103J105COM360,414$4,880,000thousands by filing date
Day One Biopharmaceuticals Inc23954D109Common Stock196,425$3,934,000thousands by filing date
IMMUNOCORE HLDGS PLC ADS45258D105ADR80,963$3,800,000thousands by filing date
EYEPOINT INC COM NEW30233G209Stock480,000$3,797,000thousands by filing date
IGM BIOSCIENCES INC449585108COM154,664$3,517,000thousands by filing date
AVADEL PHARMACEUTICALS, PLC05337M104COMMON STOCK-FO659,409$3,304,000thousands by filing date
BCLS ACQUISITION CORPG0904B105CMN300,000$3,006,000thousands by filing date
VIRACTA THERAPEUTICS INC92765F108COM689,709$2,945,000thousands by filing date
DECIBEL THERAPEUTICS INC24343R106COM801,629$2,774,000thousands by filing date
IO BIOTECH INC449778109COM1,008,437$2,733,000thousands by filing date
ALX ONCOLOGY HOLDINGS INC00166B105COMMON STOCK262,786$2,515,000thousands by filing date
TANGO THERAPEUTICS INC87583X109COM630,000$2,281,000thousands by filing date
AMRYT PHARMA LTD - SPNR ADR03217L106COMMON EQUITY304,715$2,109,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK100,000$1,936,000thousands by filing date
TERNS PHARMACEUTICALS INC COM880881107Stock289,068$1,703,000thousands by filing date
VTV THERAPEUTICS INC CL A918385105Stock1,635,509$1,586,000thousands by filing date
BOLT BIOTHERAPEUTICS INC097702104COM1,049,153$1,553,000thousands by filing date
SCIENCE 37 HOLDINGS INC808644108COM900,000$1,449,000thousands by filing date
EQUILLIUM INC29446K106COM615,541$1,367,000thousands by filing date
ALLAKOS INC01671P100COM172,089$1,053,000thousands by filing date
ELEVATION ONCOLOGY INC COM28623U101Stock830,565$939,000thousands by filing date
ALLOVIR INC019818103COM82,336$650,000thousands by filing date
SPRINGWORKS THERAPEUTICS INC85205L107COM22,204$633,000thousands by filing date
ATRECA INC04965G109COM396,835$623,000thousands by filing date
Surrozen, Inc.86889P109COM300,000$606,000thousands by filing date
AEGLEA BIOTHERAPEUTICS INC00773J103COM883,720$465,000thousands by filing date
NOVAVAX INC670002401COM NEW23,400$426,000thousands by filing datecall
NOVAVAX INC670002401COM NEW21,244$387,000thousands by filing date
KRONOS BIO INC50107A104COM78,131$262,000thousands by filing date
ASTRIA THERAPEUTICS INC COM04635X102Stock25,000$226,000thousands by filing date
NGM BIOPHARMACEUTICALS INC62921N105COM13,669$179,000thousands by filing date
KALA BIO INC COM483119103Stock601,162$132,000thousands by filing date
NUVATION BIO INC67080N119WARR133,333$27,000thousands by filing date
SURROZEN INC86889P117*W EXP 08/01/20399,999$18,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-22-118511this filing2022-11-14acceptance time not in the bulk data set